4//SEC Filing
Flynn Karen 4
Accession 0001596783-22-000014
CIK 0001596783other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 6:54 PM ET
Size
5.5 KB
Accession
0001596783-22-000014
Insider Transaction Report
Form 4
Catalent, Inc.CTLT
Flynn Karen
Pres. Biologics & CCO
Transactions
- Sale
Common Stock
2022-01-10$116.64/sh−2,472$288,334→ 33,223 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer.
- [F2]Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $116.61 to $116.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Includes restricted stock units.
Documents
Issuer
Catalent, Inc.
CIK 0001596783
Entity typeother
Related Parties
1- filerCIK 0001553599
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 6:54 PM ET
- Size
- 5.5 KB